Synthetic Drugs in East and South-East Asia
Total Page:16
File Type:pdf, Size:1020Kb
Synthetic Drugs in East and South-East Asia Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances Global SMART Programme 2019 March Acknowledgements This report was prepared by the Research and Trend Analysis Branch, Division for Policy Analysis and Public Affairs, United Nations Office on Drugs and Crime, under the supervision of Ms. Angela Me, Chief of the Research and Trend Analysis Branch, and Mr. Justice Tettey, Chief of Laboratory and Scientific Section. Core team Research and drafting Martin Raithelhuber Inshik Sim Tun Nay Soe Graphic design and layout Akara Umapornsakula Magali Lapouge Administrative support Jatupat Buasipreeda The present report also benefited from the expertise and valuable contributions of UNODC colleagues in the Regional Office for Southeast Asia and the Pacific. This publication was made possible by the generous contribution of the Governments of Australia, Canada, China, Japan, New Zealand, the Republic of Korea, the Russian Federation, Thailand, the United Kingdom, and the United States. DISCLAIMERS This publication may be reproduced in whole or in part and in any form for educational or non-profit purposes without special permission from the copyright holder, provided acknowledgement of the source is made. The content of this publication does not necessarily reflect the views or policies of UNODC, Member States or contributory organizations, and nor does it imply any endorsement. This document has not been formerly edited. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Included in this assessment are Brunei Darussalam, Cambodia, China, Hong Kong, China, Indonesia, Japan, Lao People’s Democratic Republic (Lao PDR), Malaysia, Myanmar, the Philippines, the Republic of Korea, Singapore, Thailand, and Viet Nam. The regional overview section includes data from Macau, China, Mongolia, and Taiwan Province of China. Synthetic Drugs in East and South-East Asia Trends and Patterns of Amphetamine-type Stimulants and New Psychoactive Substances A Report from the Global SMART Programme March 2019 United Nations Office on Drugs and Crime Contents General Abbreviations ...............................................................................................................................i List of Figures, Maps and Tables ..............................................................................................................iii Regional trends: East and South-East Asia ...............................................................................................1 Summary of major trends and emerging concerns .......................................................................................1 Overview of the methamphetamine market .................................................................................................1 Overview of the “ecstasy” market...............................................................................................................11 Overview of the new psychoactive substances (NPS) market .....................................................................12 Brunei Darussalam .................................................................................................................................17 Cambodia ...............................................................................................................................................21 China .....................................................................................................................................................25 Indonesia ...............................................................................................................................................31 Japan.......................................................................................................................................................35 Lao PDR ................................................................................................................................................39 Malaysia .................................................................................................................................................43 Myanmar ................................................................................................................................................47 Philippines .............................................................................................................................................51 Republic of Korea....................................................................................................................................55 Singapore ...............................................................................................................................................61 Thailand .................................................................................................................................................65 Viet Nam ................................................................................................................................................71 General Abbreviations ARQ Annual report questionnaire ATS Amphetamine-type stimulants BNN National Narcotics Board (Indonesia) CCDAC Central Committee for Drug Abuse Control (Myanmar) CNB Central Narcotics Bureau (Singapore) DAINAP Drug Abuse Information Network for Asia and the Pacific DDB Dangerous Drugs Board (Philippines) EWA UNODC Early Warning Advisory on New Psychoactive Substances HONLEA Heads of National Drug Law Enforcement Agencies (Asia and the Pacific) IDS Individual Drug Seizures INCB International Narcotics Control Board KCS Korean Customs Service Lao PDR Lao People’s Democratic Republic LCDC Lao National Commission for Drug Control and Supervision MHLW Ministry of Health, Labour and Welfare (Japan) NACD National Authority for Combating Drugs (Cambodia) NADA National Anti-Drugs Agency (Malaysia) NNCC National Narcotics Control Commission (China) NPA National Police Agency (Japan) NPS New Psychoactive Substances ONCB Office of the Narcotics Control Board (Thailand) PDEA Philippine Drug Enforcement Agency RMP Royal Malaysia Police SMART Synthetics Monitoring: Analyses, Reporting and Trends SMCC Safe Mekong Coordination Center SODC Standing Office on Drugs and Crime (Viet Nam) SPO Supreme Prosecutors’ Office (Republic of Korea) UNODC United Nations Office on Drugs and Crime i ii List of Figures, Maps and Tables Figures Regional trends: East and South-East Asia Figure 1. Potential opium production in Myanmar, 2013-2018 Figure 2. Seizures of methamphetamine in East and South-East Asia, 2013-2018* Figure 3. Proportion of methamphetamine related treatment admissions among all treatment admissions, 2017 Figure 4. Proportion of females among persons admitted to treatment centers for methamphetamine in selected countries in East and South-East Asia, 2017 Figure 5. Seizures of methamphetamine tablets in the East and South-East Asia by country, 2013-2018* Figure 6. Typical retail price of methamphetamine tablet per tablet for selected countries in East and South- East Asia, 2014 and latest year available Figure 7. Seizures of crystalline methamphetamine in East and South-East Asia by sub-region, 2013-2018* Figure 8. Number of methamphetamine manufacturing facilities dismantled in East and South-East Asia, 2013-2018* Figure 9. Photos of methamphetamine production facilities dismantled in Kutkai, North Shan, Myanmar Figure 10. Seizures of methamphetamine in China and South-East Asia, 2013-2018* Figure 11. Photos of major teabag packages found in East, South-East Asia and Oceania Figure 12. Amounts and the number of cases of pseudoephedrine seizures in Myanmar, 2013-2018 Figure 13. Seizures of sodium cyanide in Thailand and Myanmar, 2014-2018 Figure 14. Seizures of “ecstasy” in East and South-East Asia, 2013-2018* Figure 15. Appearance of NPS in East and South-East Asia by substance group, 2008-2018* Figure 16. Proportion of NPS in East and South-East Asia by pharmacological effect, 2008-2018* Figure 17. Seizures of ketamine in East and South-East Asia by sub-region, 2013-2018* Brunei Darussalam Figure 1. Number of people who use drugs brought into formal contact with authorities in Brunei Darussalam by drug type, 2013-2018 Figure 2. Number of people who use drugs brought into formal contact with authorities in Brunei Darussalam by age group, 2018 Cambodia Figure 1. Number of people who use drugs brought into formal contact with authorities in Cambodia, 2013- 2018* Figure 2. Drug treatment centre admissions in Cambodia by age group, 2017 Figure 3. Number of drug-related arrests* and cases in Cambodia, 2013-2018 Figure 4. Retail prices of methamphetamine tablet in Cambodia in USD, 2013-2017 Figure 5. Retail prices of crystalline methamphetamine in Cambodia in USD, 2013-2017 China Figure 1. Proportion of registered drug users by type of drug used in China, 2013-2018* Figure 2. Proportion of newly registered drug users by type in China, 2017 Figure 3. Number of people registered for using synthetic drug in China, 2013-2017 Figure 4. Number of illicit synthetic drug manufacturing facilities dismantled in China, 2013-2018* Figure 5. Types of NPS identified by the NPS Monitoring Programme of China,